Seminars in Fetal & Neonatal Medicine
Volume 12, Issue 4 , Pages 259-272, August 2007

Stem cell therapies for perinatal brain injuries

RY80Y-215, Merck Research Laboratories, 126E Lincoln Avenue, Rahway, NJ 07065, USA

published online 06 June 2007.

Summary 

This chapter reviews four groups of paediatric brain injury. The pathophysiology of these injuries is discussed to establish which cells are damaged and therefore which cells represent targets for cell replacement. Next, we review potential sources of cellular replacements, including embryonic stem cells, fetal and neonatal neural stem cells and a variety of mesenchymal stem cells. The advantages and disadvantages of each source are discussed. We review published studies to illustrate where stem cell therapies have been evaluated for therapeutic gain and discuss the hurdles that will need to be overcome to achieve therapeutic benefit. Overall, we conclude that children with paediatric brain injuries or inherited genetic disorders that affect the brain are worthy candidates for stem cell therapeutics.

Keywords: Children, Head injury, Hypoxia, Ischaemia, Regenerative medicine, Stem cells

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1744-165X(07)00029-7

doi:10.1016/j.siny.2007.02.003

Seminars in Fetal & Neonatal Medicine
Volume 12, Issue 4 , Pages 259-272, August 2007